E645-0745 Screening compound: N~1~-(1-benzyl-4-piperidyl)-2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]acetamide

E645-0745 Screening compound: N~1~-(1-benzyl-4-piperidyl)-2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]acetamide
E645-0745 Screening compound: N~1~-(1-benzyl-4-piperidyl)-2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E645-0745
N~1~-(1-benzyl-4-piperidyl)-2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E645-0745

Molecular Formula

C26H25ClN4O3 (C26 H25 ClN4 O3)

Compound Name

N~1~-(1-benzyl-4-piperidyl)-2-[8-chloro-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]acetamide

IUPAC name

N-(1-benzylpiperidin-4-yl)-2-{13-chloro-9-oxo-2-oxa-410-diazatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaen-10-yl}acetamide

SMILES

O=C(CN(c(cc(cc1)Cl)c1Oc1c2cccn1)C2=O)NC1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C26H25ClN4O3/c27-19-8-9-23-22(15-19)31(26(33)21-7-4-12-28-25(21)34-23)17-24(32)29-20-10-13-30(14-11-20)16-18-5-2-1-3-6-18/h1-9,12,15,20H,10-11,13-14,16-17H2,(H,29,32)

InChI Key

CMVLXBUGFJYCQL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14907607

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

476.96

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

3.496

Distribution Coefficient, logD

1.938

Water Solubility, LogSw

-3.99

Polar Surface Area

60.269

Acid Dissociation Constant (pKa)

16.36

Base Dissociation Constant (pKb)

8.95

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

E645-0745 in Drug Discovery

Included in Screening Libraries

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

GPCR Targeted Library (31838 compounds)

Protein-Protein Interaction Library (218420 compounds)

Anti-HIV1 Library (19540 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Antiviral
  • Infections
  • Immune system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E645-0745 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E645-0745?
Check Price and Availability of E645-0745, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E645-0745 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E645-0745
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E645-0745
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E645-0745 available by request